PARATEK PHARMACEUTICALS INC filings

SEC filings by PARATEK PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2023-09-05CONTINENTAL GENERAL INSURANCE COParatek Pharmaceuticals, Inc.3,693,9816.4%EDGAR
SC 13D/A2023-06-27NexPoint Real Estate Opportunities, LLCParatek Pharmaceuticals, Inc.50,0000.1%EDGAR
SC 13D2023-03-30NexPoint Real Estate Opportunities, LLCParatek Pharmaceuticals, Inc.50,0000.1%EDGAR
SC 13G/A2023-03-20HIRSCHMAN ORINParatek Pharmaceuticals, Inc.2,802,1154.9%EDGAR
SC 13G/A2023-02-15HIRSCHMAN ORINParatek Pharmaceuticals, Inc.4,156,8917.5%EDGAR
SC 13G/A2023-02-13LYTTON LAURENCE WParatek Pharmaceuticals, Inc.459,9610.8%EDGAR
SC 13G/A2023-01-20NexPoint Real Estate Opportunities, LLCParatek Pharmaceuticals, Inc.50,0000.1%EDGAR
SC 13G2022-07-08BlackRock Inc.Paratek Pharmaceuticals, Inc.869,2241.6%EDGAR
SC 13G/A2022-07-07HIRSCHMAN ORINParatek Pharmaceuticals, Inc.3,887,1727.7%EDGAR
SC 13G2022-05-18LYTTON LAURENCE WParatek Pharmaceuticals, Inc.3,210,5525.9%EDGAR
SC 13G2022-03-11DONDERO JAMES DParatek Pharmaceuticals, Inc.50,0000.0%EDGAR
SC 13G2022-03-09HIRSCHMAN ORINParatek Pharmaceuticals, Inc.2,820,0675.6%EDGAR
SC 13G/A2022-02-11HIGHBRIDGE CAPITAL MANAGEMENT LLCParatek Pharmaceuticals, Inc.2,239,9374.3%EDGAR
SC 13G/A2022-02-03BlackRock Inc.Paratek Pharmaceuticals, Inc.2,977,6805.9%EDGAR
SC 13G2021-02-12HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P.Paratek Pharmaceuticals, Inc.90,0200.2%EDGAR
SC 13G/A2021-02-09HIGHBRIDGE CAPITAL MANAGEMENT LLCParatek Pharmaceuticals, Inc.2,477,4845.2%EDGAR
SC 13G/A2021-01-29BlackRock Inc.Paratek Pharmaceuticals, Inc.3,447,3297.6%EDGAR
SC 13G/A2020-02-14ARMISTICE CAPITAL, LLCParatek Pharmaceuticals, Inc.1,258,0003.8%EDGAR
SC 13G/A2020-02-14HIGHLAND CAPITAL MANAGEMENT LPParatek Pharmaceuticals, Inc.779,3652.3%EDGAR
SC 13G/A2020-02-13HIGHBRIDGE CAPITAL MANAGEMENT LLCParatek Pharmaceuticals, Inc.2,378,9316.7%EDGAR